総資産利益率 (ROA)
2005年以降
難易度が低い
計算
Merck & Co. Inc., ROA, 長期的な傾向、計算
| ROA | = | 100 | × | Merck＆Co.、Inc.に帰属する純利益1 | ÷ | 総資産1 | |
|---|---|---|---|---|---|---|---|
| 2019/12/31 | 11.66% | = | 100 | × | 9,843 | ÷ | 84,397 |
| 2018/12/31 | 7.53% | = | 100 | × | 6,220 | ÷ | 82,637 |
| 2017/12/31 | 2.72% | = | 100 | × | 2,394 | ÷ | 87,872 |
| 2016/12/31 | 4.11% | = | 100 | × | 3,920 | ÷ | 95,377 |
| 2015/12/31 | 4.36% | = | 100 | × | 4,442 | ÷ | 101,779 |
| 2014/12/31 | 12.12% | = | 100 | × | 11,920 | ÷ | 98,335 |
| 2013/12/31 | 4.17% | = | 100 | × | 4,404 | ÷ | 105,645 |
| 2012/12/31 | 5.81% | = | 100 | × | 6,168 | ÷ | 106,132 |
| 2011/12/31 | 5.97% | = | 100 | × | 6,272 | ÷ | 105,128 |
| 2010/12/31 | 0.81% | = | 100 | × | 861 | ÷ | 105,781 |
| 2009/12/31 | 11.51% | = | 100 | × | 12,901 | ÷ | 112,090 |
| 2008/12/31 | 16.54% | = | 100 | × | 7,808 | ÷ | 47,196 |
| 2007/12/31 | 6.77% | = | 100 | × | 3,275 | ÷ | 48,351 |
| 2006/12/31 | 9.95% | = | 100 | × | 4,434 | ÷ | 44,570 |
| 2005/12/31 | 10.33% | = | 100 | × | 4,631 | ÷ | 44,846 |
ソース： Merck & Co. Inc. (NYSE:MRK) | Return on Assets since 2005 (www.stock-analysis-on.net)
1 百万ドル
競合他社との比較
Merck & Co. Inc., ROA, 長期的な傾向、競合他社との比較
| Merck & Co. Inc. | Abbott Laboratories | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Eli Lilly & Co. | Gilead Sciences Inc. | Illumina Inc. | Johnson & Johnson | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | Zoetis Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019/12/31 | 11.66% | 5.43% | 8.84% | 13.13% | 2.65% | 21.17% | 8.74% | 13.70% | 9.59% | 9.72% | 14.29% | 14.15% | 12.99% |
| 2018/12/31 | 7.53% | 3.53% | 9.58% | 12.64% | 14.06% | 7.36% | 8.57% | 11.87% | 10.00% | 7.00% | 20.83% | 33.57% | 13.25% |
| 2017/12/31 | 2.72% | 0.63% | 7.50% | 2.48% | 3.00% | -0.45% | 6.58% | 13.81% | 0.83% | 12.40% | 13.67% | 7.43% | 10.06% |
| 2016/12/31 | 4.11% | 2.66% | 9.01% | 9.95% | 13.22% | 7.05% | 23.70% | 10.81% | 11.71% | 4.20% | 12.84% | -3.87% | 10.73% |
| 2015/12/31 | 4.36% | 10.72% | 9.70% | 9.69% | 4.93% | 6.77% | 34.93% | 12.52% | 11.55% | 4.16% | 11.34% | -22.26% | 4.28% |
| 2014/12/31 | 12.12% | 5.53% | 6.44% | 7.47% | 5.94% | 6.43% | 34.91% | 10.58% | 12.45% | 5.40% | 8.99% | -31.63% | 8.82% |
| 2013/12/31 | 4.17% | 6.00% | 14.14% | 7.68% | 6.64% | 13.29% | 13.67% | 4.15% | 10.42% | 12.78% | 14.38% | -19.19% | 7.69% |
| 2012/12/31 | 5.81% | 8.87% | 19.53% | 8.00% | 5.46% | 11.89% | 12.20% | 5.89% | 8.94% | 7.84% | 36.06% | -3.88% | 6.96% |
| 2011/12/31 | 5.97% | 7.84% | — | 7.54% | 11.25% | 12.92% | 16.20% | 3.95% | 8.51% | 5.32% | -16.75% | 1.34% | — |
| 2010/12/31 | 0.81% | 7.78% | — | 10.64% | 9.98% | 16.35% | 25.03% | 6.79% | 12.96% | 4.23% | -9.59% | -43.74% | — |
| 2009/12/31 | 11.51% | 10.96% | — | 11.62% | 34.22% | 15.76% | 27.18% | 5.05% | 12.95% | 4.05% | -9.15% | -32.84% | — |
| 2008/12/31 | 16.54% | 11.51% | — | 11.51% | 17.76% | -7.09% | 28.65% | 3.67% | 15.25% | 7.29% | -12.34% | -46.90% | — |
| 2007/12/31 | 6.77% | 9.08% | — | 9.14% | 8.27% | 11.02% | 27.68% | -28.18% | 13.06% | 7.07% | -11.28% | -65.05% | — |
| 2006/12/31 | 9.95% | 4.75% | — | 8.73% | 6.20% | 12.13% | -29.12% | 13.30% | 15.67% | 16.84% | -17.49% | -22.45% | — |
| 2005/12/31 | 10.33% | 11.57% | — | 12.54% | 10.66% | 8.05% | 21.62% | -20.75% | 17.94% | 6.88% | -22.54% | -37.05% | — |
ソース： Merck & Co. Inc. (NYSE:MRK) | Return on Assets since 2005 (www.stock-analysis-on.net)
産業部門との比較： 医薬品とバイオテクノロジー
Merck & Co. Inc., ROA, 長期的な傾向、産業部門との比較： 医薬品とバイオテクノロジー
| Merck & Co. Inc. | 医薬品とバイオテクノロジー | |
|---|---|---|
| 2019/12/31 | 11.66% | 9.30% |
| 2018/12/31 | 7.53% | 9.07% |
| 2017/12/31 | 2.72% | 5.04% |
| 2016/12/31 | 4.11% | 8.67% |
| 2015/12/31 | 4.36% | 9.37% |
| 2014/12/31 | 12.12% | 9.67% |
| 2013/12/31 | 4.17% | 9.54% |
| 2012/12/31 | 5.81% | 8.55% |
| 2011/12/31 | 5.97% | 7.45% |
| 2010/12/31 | 0.81% | 7.19% |
| 2009/12/31 | 11.51% | 10.46% |
| 2008/12/31 | 16.54% | 10.91% |
| 2007/12/31 | 6.77% | 9.13% |
| 2006/12/31 | 9.95% | 11.97% |
| 2005/12/31 | 10.33% | 10.60% |
ソース： Merck & Co. Inc. (NYSE:MRK) | Return on Assets since 2005 (www.stock-analysis-on.net)
業界との比較： 健康管理
Merck & Co. Inc., ROA, 長期的な傾向、業界との比較： 健康管理
| Merck & Co. Inc. | 健康管理 | |
|---|---|---|
| 2019/12/31 | 11.66% | 8.44% |
| 2018/12/31 | 7.53% | 7.94% |
| 2017/12/31 | 2.72% | 5.12% |
| 2016/12/31 | 4.11% | 7.42% |
| 2015/12/31 | 4.36% | 7.66% |
| 2014/12/31 | 12.12% | 8.68% |
| 2013/12/31 | 4.17% | 8.86% |
| 2012/12/31 | 5.81% | 7.77% |
| 2011/12/31 | 5.97% | 7.49% |
| 2010/12/31 | 0.81% | 7.14% |
| 2009/12/31 | 11.51% | 9.39% |
| 2008/12/31 | 16.54% | 9.17% |
| 2007/12/31 | 6.77% | 8.55% |
| 2006/12/31 | 9.95% | 9.66% |
| 2005/12/31 | 10.33% | 10.28% |
ソース： Merck & Co. Inc. (NYSE:MRK) | Return on Assets since 2005 (www.stock-analysis-on.net)